YMRC
RYTM icon

Yorktown Management & Research Company’s Rhythm Pharmaceuticals RYTM Stock Holding History

Yorktown Management & Research Company’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$366K Buy
+3,300
New +$298K 0.22% 171
2026
Q1 		– Sell
-3,050
Closed -$326K – 240
2025
Q4 		$326K Buy
+3,050
New +$324K 0.26% 158

Other funds holding RYTM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Yorktown Management & Research Company's RYTM Position: Q2 2026 in Review

Yorktown Management & Research Company opened a new position in Rhythm Pharmaceuticals (RYTM) in Q2 2026: 3,300 shares worth $366K. The stake represents 0.22% of the portfolio and ranks #171 among its holdings. This is a return to the name: Yorktown Management & Research Company previously reported a position in RYTM as recently as Q4 2025.

Yorktown Management & Research Company first reported a position in RYTM in Q4 2025 and has held it in 2 quarters since. 99 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Yorktown Management & Research Company held 3,300 shares of Rhythm Pharmaceuticals worth $366K as of Q2 2026.
  • Rhythm Pharmaceuticals was a new Yorktown Management & Research Company position in Q2 2026.
  • Rhythm Pharmaceuticals made up 0.22% of Yorktown Management & Research Company's portfolio in Q2 2026, its #171 holding.
  • Yorktown Management & Research Company first reported a position in Rhythm Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 99 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Yorktown Management & Research Company's 13F filing for Q2 2026, filed 23 Jul 2026.